Cite
Mafirakureva N, Stone J, Fraser H, et al. An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis. Addiction. 2021;117(2):411-424doi: 10.1111/add.15630.
Mafirakureva, N., Stone, J., Fraser, H., Nzomukunda, Y., Maina, A., Thiong'o, A. W., Kizito, K. W., Mucara, E. W. K., González Diaz, C. I., Musyoki, H., Mundia, B., Cherutich, P., Nyakowa, M., Lizcano, J., Chhun, N., Kurth, A., Akiyama, M. J., Waruiru, W., Bhattacharjee, P., Cleland, C., Donchuk, D., Luhmann, N., Loarec, A., Maman, D., Walker, J., & Vickerman, P. (2022). An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis. Addiction (Abingdon, England), 117(2), 411-424. https://doi.org/10.1111/add.15630
Mafirakureva, Nyashadzaishe, et al. "An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis." Addiction (Abingdon, England) vol. 117,2 (2022): 411-424. doi: https://doi.org/10.1111/add.15630
Mafirakureva N, Stone J, Fraser H, Nzomukunda Y, Maina A, Thiong'o AW, Kizito KW, Mucara EWK, González Diaz CI, Musyoki H, Mundia B, Cherutich P, Nyakowa M, Lizcano J, Chhun N, Kurth A, Akiyama MJ, Waruiru W, Bhattacharjee P, Cleland C, Donchuk D, Luhmann N, Loarec A, Maman D, Walker J, Vickerman P. An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis. Addiction. 2022 Feb;117(2):411-424. doi: 10.1111/add.15630. Epub 2021 Jul 28. PMID: 34184794; PMCID: PMC8737065.
Copy
Download .nbib